Celiac disease-associated transglutaminase autoantibody target domains at diagnosis are age and sex dependent

Clinical Immunology

Volumn 109, Issue 3, 2003, Pages 318-324

  Tiberti, C ^a   Bao, F ^b   Bonamico, M ^a   Verrienti, A ^a   Picarelli, A ^a   Di Tola, M ^a   Ferri, M ^a   Vecci, E ^a   Dotta, F ^a   Eisenbarth, G S ^b   Di Mario, U ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

Autoimmunity; Celiac disease; Epitopes; Human tissue transglutaminase

Indexed keywords

AUTOANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; SULFUR 35;

ADULT; AGE DISTRIBUTION; ANTIBODY TITER; ARTICLE; ASSOCIATION; CELIAC DISEASE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; GENE CONSTRUCT; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN TARGETING; RADIOIMMUNOASSAY; SERUM; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

EID: 9144236813     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2003.08.010     Document Type: Article

References (21)

1. Sollid L.M. Coeliac disease. Nat. Rev. Immunol. 2:2002;647-655.
2. Fasano A., Catassi C. Current approaches to diagnosis and treatment of celiac disease an evolving spectrum . Gastroenterology. 120:2001;635-651.
3. Maki M., Mustalahti K., Kokkonen J., Kulmala P., Haapalahti M., Karttunen T., Ilonen J., Laurila K., Dahlbom I., Hansson T., Hopfl P., Knip M. Prevalence of celiac disease among children in Finland. N. Engl. J. Med. 348:2003;2517-2524.
4. Farrell R.J., Kelly C.P. Diagnosis of celiac sprue. Am. J. Gastroenterol. 96:2001;3237-3246.
5. Ciacci C., Cirillo M., Sollazzo R., Savino G., Sabbatici F., Mazzacca G. Gender and clinical presentation in adult celiac disease. Scand. J. Gastroenterol. 30:1995;1077-1081.
6. Dieterich W., Enhis T., Bauerm M., Donner P., Volta U., Riecken E.O., Schuppan D. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat. Med. 3:1997;725-726.
7. Schuppan D., Dieterich W., Riecken E.O. Exposing gliadin as a tasty food for lymphocytes. Nat. Med. 6:1998;666-667.
8. Molberg O., Mcadam S.N., Korner R., Quarsten H., Kristiansen C., Madsen L., Fugger L., Sco Noren O., Roepstorff P., Lundin K.E., Sjostrom H., Sollid L.M. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by derived T cells in celiac disease. Nat. Med. 4:1998;713-717.
9. Lock R.J., Pitcher M.C.L., Unsworth D.J. IgA anti-tissue transglutaminase as a diagnostic marker of gluten sensitivity enteropathy. J. Clin. Pathol. 52:1999;274-277.
10. Bonamico M., Tiberti C., Picarelli A., Mariani P., Rossi D., Cipolletta E., Greco M., Di Tola M., Sabbatella L., Carabba B., Magliocca M., Strisciuglio P., Di Mario U. Radioimmunoassay to detect antitransglutaminase autoantibodies is the most sensitive and specific screening method for celiac disease. Am. J. Gastroenterol. 96:2001;1536-1540.
11. Seissler J., Wohlrab U., Wuensche C., Sherbaum W.A., Boehm B.O. Autoantibodies from patients with coeliac disease recognize distinct functional domains of the autoantigen tissue transglutaminase. Clin. Exp. Immunol. 125:2001;216-221.
12. Sblattero D., Florian F., Azzoni E., Zyla T., Park M., Baldas V., Not T., Ventura A., Bradbury A., Marzari R. The analysis of the fine specificity of coeliac disease antibodies using tissue transglutaminase fragments. Eur. J. Biochem. 269:2002;5175-5181.
13. Kawasaki E., Sera Y., Abiru N., Yamauchi M., Ozaki M., Yamakawa K., Abe T., Uotani S., Yamasaki H., Yamaguchi Y., Eguchi K. Distinct IA-2 autoantibody epitope recognition between childhood-onset and adult-onset type 1 diabetes. Ann. NY Acad. Sci. 958:2002;235-240.
14. Walker-Smith J.A., Guandalini S., Schmitz J., Shmerling D.H., Visakorpi J.K. Revised criteria for diagnosis of celiac disease. Arch. Dis. Child. 65:1990;909-911.
15. Farilla L., Tiberti C., Luzzago A., Yu L., Eisenbarth G.S., Cortese R., Dotta F., Di Mario U. Application of phage display peptide library to autoimmune diabetes identification of IA-2/ICA512bdc dominant autoantigenic epitopes . Eur. J. Immunol. 32:2002;1420-1427.
16. Naserke H.E., Ziegler A.G., Lampasona V., Bonifacio E. Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes. J. Immunol. 161:1998;6963-6969.
17. Söhnlein P., Müller M., Syren K., Hartmann U., Bohm B.O., Meinck H.M., Knip M., Akerblom H.K., Richter W. Epitope spreading and a varying but nor disease-specific GAD65 antibody response in type 1 diabetes. Diabetologia. 43:2000;210-217.
18. Savola K., Bonifacio E., Sabbah E., Kulmala P., Vähäsalo P., Karjalainen A., Tuomilehto-Wolf E., Meriläinen J., Åkerblom H.K., Knip M. Childhood Diabetes Finland Study Group. IA-2 antibodies a sensitive marker of IDDM with clinical onset in childhood and adolescence, The Childhood Diabetes in Finland Study Group . Diabetologia. 41:1998;424-429.
19. Sabbah E., Savola K., Kulmla P., Veicola R., Vahasalo P., Karjalainen J., Åkerblom H.K., Knip M. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes, The Childhood Diabetes in Finland Study Group. J. Clin. Endocrinol. Metab. 84:1999;1534-1539.
20. Kordonouri O., Hartmann R., Gruters-Kieslich A., Knip M., Danne T. Age-specific levels of diabetes-related GAD and IA-2 antibodies in healthy children and adults. J. Pediatr. Endocrinol. Metab. 15:2002;47-52.
21. Whitacre C.C. Sex differences in autoimmune disease. Nat. Immunol. 2:2001;777-780.